Publication:
Antiviral drugs and acute kidney injury (AKI)

dc.contributor.authorWattana Leowattanaen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2020-01-27T07:52:19Z
dc.date.available2020-01-27T07:52:19Z
dc.date.issued2019-01-01en_US
dc.description.abstract© 2019 Bentham Science Publishers. The introduction of more efficient antiviral drugs are common cause drug-induced acute kidney injury (AKI). The true prevalence of antiviral drugs induced nephrotoxicity is hardly determined. It causes AKI by many mechanisms including acute tubular necrosis (ATN), allergic interstitial nephritis (AIN), and crystal nephropathy. ATN has been described with a few kinds of antiviral drugs such as cidofovir, adefovir and tenofovir with unique effects on transporter defects, apoptosis, and mitochondrial injury. AIN from atazanavir is a rapid onset of AKI and usually non-oliguric but dialytic therapy are needed because of severity. Additionally, crystal nephropathy from acyclovir, indinavir, and foscarnet can cause AKI due to intratubular obstruction. In this article, the mechanisms of antiviral drug-induced AKI were reviewed and strategies for preventing AKI were mentioned.en_US
dc.identifier.citationInfectious Disorders - Drug Targets. Vol.19, No.4 (2019), 375-382en_US
dc.identifier.doi10.2174/1871526519666190617154137en_US
dc.identifier.issn18755852en_US
dc.identifier.issn18715265en_US
dc.identifier.other2-s2.0-85077296781en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/50307
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85077296781&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectMedicineen_US
dc.titleAntiviral drugs and acute kidney injury (AKI)en_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85077296781&origin=inwarden_US

Files

Collections